Figure 3From: Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancerEffects of DZNeP on PS and CSC markers. A, representative picture of cells grown in SCM for 7 days. B, C PS number and volume in untreated and treated cells (1 μM, 7 days). Columns, mean volume; bars standard deviation. D, CSC marker expression. LNCaP cells were treated with DZNeP (1 μM, 3 days) and then sorted as described under "Flow cytometric analysis and separation".Back to article page